吡格列酮-话题@MedSci

#吡格列酮#

57篇内容 | 2890人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2157826, encodeId=d0d1215e82602, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a> 2型糖尿病和骨质疏松症都是随着年龄增长而患病率增加的疾病，尤其是绝经后妇女。糖尿病与骨质疏松症之间存在复杂的关系，骨质疏松导致骨折的风险，在糖尿病(DM)患者中高出2 - 6倍。因此，所有绝经后糖尿病患者都应该进行骨质疏松相关的筛查。虽然很多年前就已经知道糖尿病和骨质疏松症之间的关系，但是最近才开始进行T2DM患者骨折风险的临床筛查，并发现他们的骨密度值高于非糖尿病患者。, objectTitle=吡格列酮, objectType=topic, longId=39186, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=85, createdTime=2023-09-15, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, status=1, hasArticle=0, attachment=null, ipAttribution=浙江省, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=2129496, encodeId=6c9f2129496fb, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>的使用降低<a href='/topic/show?id=fa10e93597f' target=_blank style='color:#2F92EE;'>#缺血性卒中#</a><a href='/topic/show?id=4f77e665253' target=_blank style='color:#2F92EE;'>#糖尿病#</a>患者的<a href='/topic/show?id=18b3e120514' target=_blank style='color:#2F92EE;'>#痴呆#</a>风险，吡格列酮还是好药呀！！未来还是值得开发的。, objectTitle=Neurology：吡格列酮的使用降低缺血性中风糖尿病患者的痴呆风险 , objectType=article, longId=768418, objectId=f235e684189c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668024264698_4754896.jpeg, objectUrl=/article/show_article.do?id=f235e684189c, replyNumber=0, likeNumber=212, createdTime=2023-05-01, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f235e684189c, moduleTitle=Neurology：吡格列酮的使用降低缺血性中风糖尿病患者的痴呆风险 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f235e684189c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2117666, encodeId=c1ed211e6665a, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a><a href='/topic/show?id=18b3e120514' target=_blank style='color:#2F92EE;'>#痴呆#</a><a href='/topic/show?id=9efb80281aa' target=_blank style='color:#2F92EE;'>#老药新用#</a>，值得研究, objectTitle=糖尿病二线老药焕发新机！Neurology：该药可降低16%痴呆风险，这些人还获益更大..., objectType=article, longId=760293, objectId=7204e6029337, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230221/1676949303754_5490734.jpg, objectUrl=/article/show_article.do?id=7204e6029337, replyNumber=0, likeNumber=189, createdTime=2023-03-05, rootId=0, userName=lifestar, userId=aa0e14, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7204e6029337, moduleTitle=糖尿病二线老药焕发新机！Neurology：该药可降低16%痴呆风险，这些人还获益更大..., moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7204e6029337)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448024, encodeId=fe391448024ad, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Horm Metab Res：二甲双胍联合吡格列酮可降低PCOS患者的炎症水平, objectType=article, longId=201467, objectId=e74020146e20, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e74020146e20, replyNumber=0, likeNumber=149, createdTime=2020-10-03, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e74020146e20, moduleTitle=Horm Metab Res：二甲双胍联合吡格列酮可降低PCOS患者的炎症水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e74020146e20)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448023, encodeId=abe31448023d1, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=JCEM：吡格列酮可降低胰岛素治疗的2型糖尿病患者全因死亡风险, objectType=article, longId=179952, objectId=08531e9952bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=08531e9952bf, replyNumber=0, likeNumber=126, createdTime=2019-09-25, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=08531e9952bf, moduleTitle=JCEM：吡格列酮可降低胰岛素治疗的2型糖尿病患者全因死亡风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=08531e9952bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448022, encodeId=441a1448022be, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Stroke：选择适合者使用吡格列酮预防卒中, objectType=article, longId=161159, objectId=9581161159e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9581161159e7, replyNumber=0, likeNumber=104, createdTime=2019-02-27, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9581161159e7, moduleTitle=Stroke：选择适合者使用吡格列酮预防卒中, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9581161159e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448021, encodeId=fb0d144802172, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Stroke：基于骨折风险的脑卒中后吡格列酮治疗评分系统, objectType=article, longId=155594, objectId=70fe155594f2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70fe155594f2, replyNumber=0, likeNumber=101, createdTime=2018-12-12, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70fe155594f2, moduleTitle=Stroke：基于骨折风险的脑卒中后吡格列酮治疗评分系统, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70fe155594f2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448020, encodeId=3f2f144802078, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Diabetes Obes Metab：吡格列酮可降低2型糖尿病患者的卒中风险？, objectType=article, longId=148196, objectId=5e051481968e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e051481968e, replyNumber=0, likeNumber=88, createdTime=2018-09-06, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e051481968e, moduleTitle=Diabetes Obes Metab：吡格列酮可降低2型糖尿病患者的卒中风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e051481968e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448019, encodeId=0d4414480197b, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Int J Impot Res：吡格列酮对阴茎勃起功能保护作用可以通过抑制类胰岛素生长因子-1受体抑制消除, objectType=article, longId=146544, objectId=cceb1465445c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cceb1465445c, replyNumber=0, likeNumber=93, createdTime=2018-08-15, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cceb1465445c, moduleTitle=Int J Impot Res：吡格列酮对阴茎勃起功能保护作用可以通过抑制类胰岛素生长因子-1受体抑制消除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cceb1465445c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448018, encodeId=502e144801898, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Clin Gastroenterol H：吡格列酮治疗非酒精性脂肪肝合并vs不合并2型糖尿病, objectType=article, longId=135663, objectId=9409135663e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9409135663e2, replyNumber=0, likeNumber=103, createdTime=2018-04-19, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9409135663e2, moduleTitle=Clin Gastroenterol H：吡格列酮治疗非酒精性脂肪肝合并vs不合并2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9409135663e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448017, encodeId=7d87144801eb9, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Diabetologia：使用吡格列酮治疗痴呆的风险更低?, objectType=article, longId=134769, objectId=5527134e6985, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5527134e6985, replyNumber=0, likeNumber=87, createdTime=2018-04-12, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5527134e6985, moduleTitle=Diabetologia：使用吡格列酮治疗痴呆的风险更低?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5527134e6985)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448016, encodeId=d3a2144801633, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=吡格列酮二甲双胍复方制剂临床应用专家建议, objectType=article, longId=127738, objectId=f9ec12e738f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f9ec12e738f9, replyNumber=0, likeNumber=84, createdTime=2018-01-27, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f9ec12e738f9, moduleTitle=吡格列酮二甲双胍复方制剂临床应用专家建议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f9ec12e738f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448015, encodeId=74641448015c3, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Rheumatology：吡格列酮可降低糖尿病患者痛风的发病率, objectType=article, longId=127661, objectId=d2b612e66198, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2b612e66198, replyNumber=0, likeNumber=100, createdTime=2018-01-26, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2b612e66198, moduleTitle=Rheumatology：吡格列酮可降低糖尿病患者痛风的发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2b612e66198)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448014, encodeId=abea144801497, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Cardiovasc Diabetol：吡格列酮对心血管疾病患者的不良结局有何影响？, objectType=article, longId=124978, objectId=47ef1249e89d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47ef1249e89d, replyNumber=0, likeNumber=97, createdTime=2017-12-30, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47ef1249e89d, moduleTitle=Cardiovasc Diabetol：吡格列酮对心血管疾病患者的不良结局有何影响？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47ef1249e89d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448013, encodeId=32cc1448013ad, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Lancet Diabetes Endo：吡格列酮的心血管风险如何？, objectType=article, longId=124758, objectId=d28d124e589d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d28d124e589d, replyNumber=0, likeNumber=86, createdTime=2017-12-28, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d28d124e589d, moduleTitle=Lancet Diabetes Endo：吡格列酮的心血管风险如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d28d124e589d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448012, encodeId=378d144801249, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=JDI：发现吡格列酮与糖尿病患者血清瘦素水平的关系, objectType=article, longId=124284, objectId=1d8812428492, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d8812428492, replyNumber=0, likeNumber=116, createdTime=2017-12-24, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d8812428492, moduleTitle=JDI：发现吡格列酮与糖尿病患者血清瘦素水平的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d8812428492)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448011, encodeId=9ad8144801122, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Clin Gastroenterol Hepatol：相比糖尿病前期患者，吡格列酮显著降低了2型糖尿病患者肝纤维化，并增加了脂肪组织胰岛素敏感性, objectType=article, longId=123234, objectId=d020123234b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d020123234b4, replyNumber=0, likeNumber=67, createdTime=2017-12-14, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d020123234b4, moduleTitle=Clin Gastroenterol Hepatol：相比糖尿病前期患者，吡格列酮显著降低了2型糖尿病患者肝纤维化，并增加了脂肪组织胰岛素敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d020123234b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448010, encodeId=3063144801001, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=JAMA N：卒中二级预防，吡格列酮对高风险者更加有效, objectType=article, longId=122640, objectId=c097122640e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c097122640e2, replyNumber=0, likeNumber=0, createdTime=2017-12-09, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c097122640e2, moduleTitle=JAMA N：卒中二级预防，吡格列酮对高风险者更加有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c097122640e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448009, encodeId=aece144800991, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=Circulation：吡格列酮预防近期TIA或缺血性卒中患者卒中再发！, objectType=article, longId=118303, objectId=2b2911830393, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b2911830393, replyNumber=0, likeNumber=98, createdTime=2017-11-02, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b2911830393, moduleTitle=Circulation：吡格列酮预防近期TIA或缺血性卒中患者卒中再发！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b2911830393)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1448008, encodeId=881e1448008ef, content=<a href='/topic/show?id=dec73918624' target=_blank style='color:#2F92EE;'>#吡格列酮#</a>, objectTitle=J Diabetes Investig:吡格列酮对脂肪萎缩的糖尿病影响有限, objectType=article, longId=113570, objectId=b0e21135e0c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b0e21135e0c5, replyNumber=0, likeNumber=98, createdTime=2017-09-23, rootId=0, userName=bioon5, userId=28075374720, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b0e21135e0c5, moduleTitle=J Diabetes Investig:吡格列酮对脂肪萎缩的糖尿病影响有限, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b0e21135e0c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

吡格列酮

2020-05-29

yangchou (审核中...)

前往app查看评论内容

全文收起 #吡格列酮# 2型糖尿病和骨质疏松症都是随着年龄增长而患病率增加的疾病，尤其是绝经后妇女。糖尿病与骨质疏松症之间存在复杂的关系，骨质疏松导致骨折的风险，在糖尿病(DM)患者中高出2 - 6倍。因此，所有绝经后糖尿病患者都应该进行骨质疏松相关的筛查。虽然很多年前就已经知道糖尿病和骨质疏松症之间的关系，但是最近才开始进行T2DM患者骨折风险的临床筛查，并发现他们的骨密度值高于非糖尿病患者。

2023-09-15发表于浙江省

侠胆医心 (审核中...)

前往app查看评论内容

#吡格列酮#的使用降低#缺血性卒中##糖尿病#患者的#痴呆#风险，吡格列酮还是好药呀！！未来还是值得开发的。

Neurology：吡格列酮的使用降低缺血性中风糖尿病患者的痴呆风险

2023-05-01发表于上海

lifestar (审核中...)

前往app查看评论内容

#吡格列酮##痴呆##老药新用#，值得研究

糖尿病二线老药焕发新机！Neurology：该药可降低16%痴呆风险，这些人还获益更大...

2023-03-05发表于上海

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Horm Metab Res：二甲双胍联合吡格列酮可降低PCOS患者的炎症水平

2020-10-03

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

JCEM：吡格列酮可降低胰岛素治疗的2型糖尿病患者全因死亡风险

2019-09-25

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Stroke：选择适合者使用吡格列酮预防卒中

2019-02-27

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Stroke：基于骨折风险的脑卒中后吡格列酮治疗评分系统

2018-12-12

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Diabetes Obes Metab：吡格列酮可降低2型糖尿病患者的卒中风险？

2018-09-06

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Int J Impot Res：吡格列酮对阴茎勃起功能保护作用可以通过抑制类胰岛素生长因子-1受体抑制消除

2018-08-15

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Clin Gastroenterol H：吡格列酮治疗非酒精性脂肪肝合并vs不合并2型糖尿病

2018-04-19

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Diabetologia：使用吡格列酮治疗痴呆的风险更低?

2018-04-12

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

吡格列酮二甲双胍复方制剂临床应用专家建议

2018-01-27

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Rheumatology：吡格列酮可降低糖尿病患者痛风的发病率

2018-01-26

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Cardiovasc Diabetol：吡格列酮对心血管疾病患者的不良结局有何影响？

2017-12-30

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Lancet Diabetes Endo：吡格列酮的心血管风险如何？

2017-12-28

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

JDI：发现吡格列酮与糖尿病患者血清瘦素水平的关系

2017-12-24

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Clin Gastroenterol Hepatol：相比糖尿病前期患者，吡格列酮显著降低了2型糖尿病患者肝纤维化，并增加了脂肪组织胰岛素敏感性

2017-12-14

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

JAMA N：卒中二级预防，吡格列酮对高风险者更加有效

2017-12-09

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

Circulation：吡格列酮预防近期TIA或缺血性卒中患者卒中再发！

2017-11-02

bioon5 (审核中...)

前往app查看评论内容

#吡格列酮#

J Diabetes Investig:吡格列酮对脂肪萎缩的糖尿病影响有限

2017-09-23

科室
- - 订阅+
  - 更多科室
工具
服务